Artificial Pancreas Market

1. Executive Summary
    1.1. Key Market Insights

2. Introduction
    2.1. Study Objectives
    2.2. Market Definition
           2.2.1. Market Covered
           2.2.2. Regional Coverage
           2.2.3. Study Years & Currency
    2.3. Market Stakeholders
    2.4. Key Questions this Study will Answer
    2.5. GMI Research’s Approach & Methodology
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Artificial Pancreas Market - Overview
    3.1. Introduction
    3.2. Market Segmentation
    3.3. Value Chain Analysis
    3.4. Market Drivers
    3.5. Market Restraints
    3.6. Market Trends

4. Global Artificial Pancreas Market Revenue Forecast till 2029

5. Global Artificial Pancreas Market by Product Type Forecast till 2029
    5.1. Insulin
    5.2. Bi-Hormonal
    5.3. Hybrid

6. Global Artificial Pancreas Market by End User Revenue Forecast till 2029
    6.1. Hospitals
    6.2. Clinics
    6.3. Others

7. Global Artificial Pancreas Market by Geography Revenue Forecast till 2029
    7.1. North America Artificial Pancreas Market Revenue Forecast till 2029
           7.1.1. North America Artificial Pancreas Market by Product Type (Option 1: 25% customization)
                     7.1.1.1. Insulin
                     7.1.1.2. Bi-Hormonal
                     7.1.1.3. Hybrid
           7.1.2. North America Artificial Pancreas Market by End User
                     7.1.2.1. Hospitals
                     7.1.2.2. Clinics
                     7.1.2.3. Others
    7.2. Europe Artificial Pancreas Market Revenue Forecast till 2029
           7.2.1. Europe Artificial Pancreas Market by Product Type (Option 2: 25% customization)
                     7.2.1.1. Insulin
                     7.2.1.2. Bi-Hormonal
                     7.2.1.3. Hybrid
           7.2.2. Europe Artificial Pancreas Market by End User
                     7.2.2.1. Hospitals
                     7.2.2.2. Clinics
                     7.2.2.3. Others
    7.3. Asia-Pacific Artificial Pancreas Market Revenue Forecast till 2029
           7.3.1. Asia-Pacific Artificial Pancreas Market by Product Type (Option 3: 25% customization)
                     7.3.1.1. Inssulin
                     7.3.1.2. Bi-Hormonal
                     7.3.1.3. Hybrid
           7.3.2. Asia-Pacific Artificial Pancreas Market by End User
                     7.3.2.1. Hospitals
                     7.3.2.2. Clinics
                     7.3.2.3. Others
    7.4. Rest of the World Artificial Pancreas Market Revenue Forecast till 2029
           7.4.1. Rest of the World Artificial Pancreas Market by Product Type (Option 4: 25% customization)
                     7.4.1.1. Insulin
                     7.4.1.2. Bi-Hormonal
                     7.4.1.3. Hybrid
           7.4.2. Rest of the World Surgical Laser Market by End user
                     7.4.2.1. Hospital
                     7.4.2.2. Clinics
                     7.4.2.3. Other

8. Competitive Landscape
    8.1. Porter’s Five Forces Analysis
    8.2. Industry – Competitive Landscape
    8.3. Market Presence (Intensity Mapping)
    8.4. Key Strategic Market Developments

9. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)

    9.1. Abbott Laboratories
           9.1.1. Company Overview
           9.1.2. Key Executives
           9.1.3. Footprint & Employee Strength
           9.1.4. Product Offerings
           9.1.5. Financials
           9.1.6. Key Company Developments

    9.2. Becton Dickinson and Company
           9.2.1. Company Overview
           9.2.2. Key Executives
           9.2.3. Footprint & Employee Strength
           9.2.4. Product Offerings
           9.2.5. Financials
           9.2.6. Key Company Developments

    9.3. Bayer Healthcare
           9.3.1. Company Overview
           9.3.2. Key Executives
           9.3.3. Footprint & Employee Strength
           9.3.4. Product Offerings
           9.3.5. Financials
           9.3.6. Key Company Developments

    9.4. Roche Holding AG
           9.4.1. Company Overview
           9.4.2. Key Executives
           9.4.3. Footprint & Employee Strength
           9.4.4. Product Offerings
           9.4.5. Financials
           9.4.6. Key Company Developments

    9.5. Medtronic plc
           9.5.1. Company Overview
           9.5.2. Key Executives
           9.5.3. Footprint & Employee Strength
           9.5.4. Product Offerings
           9.5.5. Financials
           9.5.6. Key Company Developments

    9.6. Dexcom Inc.
           9.6.1. Company Overview
           9.6.2. Key Executives
           9.6.3. Footprint & Employee Strength
           9.6.4. Product Offerings
           9.6.5. Financials
           9.6.6. Key Company Developments

    9.7. Biotronik SE
           9.7.1. Company Overview
           9.7.2. Key Executives
           9.7.3. Footprint & Employee Strength
           9.7.4. Product Offerings
           9.7.5. Financials
           9.7.6. Key Company Developments

    9.8. GlaxoSmithKline
           9.8.1. Company Overview
           9.8.2. Key Executives
           9.8.3. Footprint & Employee Strength
           9.8.4. Product Offerings
           9.8.5. Financials
           9.8.6. Key Company Developments

10. About GMI Research